BioLineRx Ltd.
BLRX
$2.94
-$0.16-5.16%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -8.34% | -21.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.34% | -21.33% | |||
| Cost of Revenue | -8.36% | -38.35% | |||
| Gross Profit | -8.34% | -16.74% | |||
| SG&A Expenses | -13.69% | 4.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.49% | -4.38% | |||
| Operating Income | 6.69% | -19.72% | |||
| Income Before Tax | -1,302.89% | 169.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,302.89% | 169.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,302.89% | 169.54% | |||
| EBIT | 6.69% | -19.72% | |||
| EBITDA | 14.16% | -34.96% | |||
| EPS Basic | -1,325.00% | 166.67% | |||
| Normalized Basic EPS | -1,100.00% | 175.00% | |||
| EPS Diluted | -1,325.00% | 166.67% | |||
| Normalized Diluted EPS | -1,100.00% | 175.00% | |||
| Average Basic Shares Outstanding | 0.16% | 10.21% | |||
| Average Diluted Shares Outstanding | 0.16% | 10.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
